Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00636844 · ClinicalTrials.gov registry record
Detection of Chemotherapy Induced Cardiotoxicity
A clinical trial, sponsored by George Washington University.
- Completed
- Registry status
- 36
- Enrollment target
NCT00636844: Completed study, sponsored by George Washington University.
NCT00636844 is a clinical trial that has completed, run by George Washington University. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00636844 has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
To identify patients that are at risk of heart damage after receiving chemotherapy (adriamycin).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2008-01 |
| Est. Completion | 2012-06 |
What the finished NCT00636844 record still lists
NCT00636844 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00636844 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00636844 about?
NCT00636844 is a clinical study titled "Detection of Chemotherapy Induced Cardiotoxicity". To identify patients that are at risk of heart damage after receiving chemotherapy (adriamycin).
What is the current status of trial NCT00636844?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2008-01. Estimated completion is 2012-06.
Who is sponsoring clinical trial NCT00636844?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia